Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Merck
Colorcon
McKesson
Baxter

Last Updated: May 19, 2022

CLINICAL TRIALS PROFILE FOR WELLCOVORIN


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Wellcovorin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002524 ↗ Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma Completed National Cancer Institute (NCI) Phase 2 1993-06-01 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with AIDS-related lymphoma.
NCT00002524 ↗ Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma Completed M.D. Anderson Cancer Center Phase 2 1993-06-01 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with AIDS-related lymphoma.
NCT00002525 ↗ Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed Terminated American College of Surgeons Phase 3 1993-08-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more tumor cells. It is not yet known if surgery is more effective with or without chemotherapy for colon cancer. PURPOSE: Randomized phase III trial to evaluate whether perioperative 5-Fluorouracil (5-FU) chemotherapy after curative resection could improve overall survival and disease-free survival in patients with Duke's B3 or C colon cancer.
NCT00002525 ↗ Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed Terminated Cancer and Leukemia Group B Phase 3 1993-08-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more tumor cells. It is not yet known if surgery is more effective with or without chemotherapy for colon cancer. PURPOSE: Randomized phase III trial to evaluate whether perioperative 5-Fluorouracil (5-FU) chemotherapy after curative resection could improve overall survival and disease-free survival in patients with Duke's B3 or C colon cancer.
NCT00002525 ↗ Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed Terminated National Cancer Institute (NCI) Phase 3 1993-08-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more tumor cells. It is not yet known if surgery is more effective with or without chemotherapy for colon cancer. PURPOSE: Randomized phase III trial to evaluate whether perioperative 5-Fluorouracil (5-FU) chemotherapy after curative resection could improve overall survival and disease-free survival in patients with Duke's B3 or C colon cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Wellcovorin

Condition Name

Condition Name for Wellcovorin
Intervention Trials
Acute Lymphoblastic Leukemia 13
Leukemia 12
Untreated Adult Acute Lymphoblastic Leukemia 9
B Acute Lymphoblastic Leukemia 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Wellcovorin
Intervention Trials
Precursor Cell Lymphoblastic Leukemia-Lymphoma 30
Leukemia 30
Leukemia, Lymphoid 29
Adenocarcinoma 26
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Wellcovorin

Trials by Country

Trials by Country for Wellcovorin
Location Trials
Canada 149
Australia 65
New Zealand 25
Puerto Rico 19
Switzerland 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Wellcovorin
Location Trials
Texas 51
California 42
New York 38
Michigan 38
Missouri 37
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Wellcovorin

Clinical Trial Phase

Clinical Trial Phase for Wellcovorin
Clinical Trial Phase Trials
Phase 3 26
Phase 2/Phase 3 2
Phase 2 36
[disabled in preview] 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Wellcovorin
Clinical Trial Phase Trials
Completed 38
Recruiting 21
Active, not recruiting 17
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Wellcovorin

Sponsor Name

Sponsor Name for Wellcovorin
Sponsor Trials
National Cancer Institute (NCI) 71
Children's Oncology Group 17
M.D. Anderson Cancer Center 17
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Wellcovorin
Sponsor Trials
Other 89
NIH 71
Industry 22
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Boehringer Ingelheim
Merck
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.